Spruce Biosciences Inc. (SPRB) NASDAQ
$1.49 0.09 (6.43%)
Market Cap: $60.66M
As of 12/01/23 04:00 PM EST. Market closed.
Spruce Biosciences Inc. (SPRB)
NASDAQ
$1.49
0.09 (6.43%)
Market Cap: $60.66M
As of 12/01/23 04:00 PM EST. Market closed.
Add to Portfolio
spruce biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine ... read more
spruce biosciences is a clinical stage biopharmaceutical company focused on developing novel therapies for rare diseases affecting the endocrine system. read less
COMPANY PROFILE
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Sector
Manufacturing
Industry
Pharmaceutical Preparation Manufacturing
Full Time Employees
31
Address
.
PRICE CHART FOR SPRUCE BIOSCIENCES INC
From:
To:
NEWS
INSIDEARBITRAGE ARTICLES
KEY STATS
Open
$1.45
Previous Close
$1.40
Days Range
$1.44 - $1.51
52 week range
$0.95 - $3.57
Volume
58,288
Avg. Volume (30 days)
135,962
Market Cap
$60.66M
Dividend Yield
-
P/E
-
Shares Outstanding
40,710,692
Open
$1.45
Previous Close
$1.40
Days Range
$1.44 - $1.51
52 week range
$0.95 - $3.57
Volume
58,288
Avg. Volume (30 days)
135,962
Market Cap
$60.66M
Dividend Yield
-
P/E
-
Shares Outstanding
40,710,692
FINANCIAL STATEMENTS FOR SPRUCE BIOSCIENCES INC
LOADING...
Open in: 
Open in:
INSIDER TRANSACTIONS FOR SPRUCE BIOSCIENCES INC
| Owner | Relationship | Date | Transaction | Cost | # Shares | Value($) | Total Shares | Form 4 |
| Charlton Ralph William III | Chief Medical Officer | Jun 30, 2023 | Option Exercise | $0.98 | 12,378 | 12,099 | 25,242 | Jul 05, 2023, 06:03 PM |
| Szwarcberg Javier B. | Chief Executive Officer | Jun 30, 2023 | Option Exercise | $0.98 | 20,000 | 19,550 | 34,705 | Jul 05, 2023, 06:01 PM |
| Gharib Samir M. | President & CFO | Jun 30, 2023 | Option Exercise | $0.98 | 10,484 | 10,248 | 66,302 | Jul 05, 2023, 06:00 PM |
| Gharib Samir M. | President & CFO | Jun 30, 2023 | Option Exercise | $2.15 | 25,936 | 55,762 | 115,366 | Jul 05, 2023, 06:00 PM |
| O'Donnell Niall | Director | Feb 16, 2023 | Buy | $3.17 | 630,400 | 1,998,368 | 1,326,305 | May 16, 2023, 04:08 PM |
| Novo Holdings A/S | 10% Owner | Feb 16, 2023 | Buy | $3.17 | 2,208,000 | 6,999,360 | 6,722,336 | Feb 21, 2023, 04:19 PM |
| Charlton Ralph William III | Chief Medical Officer | Dec 30, 2022 | Option Exercise | $0.93 | 12,864 | 12,000 | 12,864 | Jan 05, 2023, 08:13 PM |
| Szwarcberg Javier B. | Chief Executive Officer | Dec 30, 2022 | Option Exercise | $0.93 | 14,705 | 13,717 | 14,705 | Jan 05, 2023, 08:12 PM |
| Gharib Samir M. | President & CFO | Dec 30, 2022 | Option Exercise | $0.93 | 1 | 1 | 33,611 | Jan 05, 2023, 08:11 PM |
| Gharib Samir M. | President & CFO | Jan 03, 2023 | Option Exercise | $1.15 | 15,293 | 17,587 | 55,818 | Jan 05, 2023, 08:11 PM |
| Gharib Samir M. | President & CFO | Jun 30, 2022 | Option Exercise | $1.48 | 5,446 | 8,055 | 46,578 | Jul 05, 2022, 04:04 PM |
| Gharib Samir M. | President & CFO | Jun 30, 2022 | Option Exercise | $1.74 | 12,968 | 22,564 | 33,610 | Jul 05, 2022, 04:04 PM |
| SIMPSON CAMILLA V | Director | May 20, 2021 | Option Exercise | $0.85 | 334 | 284 | 334 | May 21, 2021, 09:10 PM |
| SIMPSON CAMILLA V | Director | May 20, 2021 | Sale | $15.29 | 334 | 5,107 | 0 | May 21, 2021, 09:10 PM |
| Novo Holdings A/S | 10% Owner | May 19, 2021 | Sale | $13.90 | 475,000 | 6,602,500 | 4,514,336 | May 21, 2021, 04:32 PM |
| SIMPSON CAMILLA V | Director | Apr 30, 2021 | Option Exercise | $0.85 | 14,045 | 11,938 | 14,045 | May 04, 2021, 09:09 PM |
| SIMPSON CAMILLA V | Director | Apr 30, 2021 | Sale | $16.14 | 14,045 | 226,664 | 0 | May 04, 2021, 09:09 PM |
| Novo Holdings A/S | 10% Owner | Oct 14, 2020 | Buy | $15.00 | 250,000 | 3,750,000 | 4,989,336 | Oct 16, 2020, 04:49 PM |
| RiverVest Venture Fund III, L.P. | 10% Owner | Oct 14, 2020 | Buy | $15.00 | 250,000 | 3,750,000 | 2,148,281 | Oct 16, 2020, 12:34 PM |
| Muralidhar Bali | Director | Oct 14, 2020 | Buy | $15.00 | 200,000 | 3,000,000 | 1,792,518 | Oct 16, 2020, 12:24 PM |
| O'Donnell Niall | Director | Oct 14, 2020 | Buy | $15.00 | 250,000 | 3,750,000 | 695,905 | Oct 16, 2020, 12:21 PM |
| Omega Fund VI, L.P. | Former 10% Owner | Oct 14, 2020 | Buy | $15.00 | 250,000 | 3,750,000 | 2,161,022 | Oct 16, 2020, 12:15 PM |
| Chaya Moghrabi Dina | Director | Oct 14, 2020 | Buy | $15.00 | 250,000 | 3,750,000 | 2,161,022 | Oct 16, 2020, 12:14 PM |
| HealthCap VIII, L.P. | Former 10% Owner | Oct 14, 2020 | Buy | $15.00 | 250,000 | 3,750,000 | 2,033,621 | Oct 16, 2020, 12:08 PM |
| HANSSON JONAS | Director | Oct 14, 2020 | Buy | $15.00 | 250,000 | 3,750,000 | 2,033,621 | Oct 16, 2020, 12:07 PM |
Load More Insider Transactions
Buy
Sale
Option Exercise
Load More Insider Transactions
FUNDS WITH A POSITION IN SPRUCE BIOSCIENCES INC
| Fund | # Shares Owned | % of Portfolio | % Change | Investing Style |
|---|---|---|---|---|
| BLACKROCK INC. | 258,501 | 0.00002% | -0.95% | Other |
| RENAISSANCE TECHNOLOGIES LLC | 207,776 | 0.0008% | -13.1% | Other |
| GEODE CAPITAL MANAGEMENT, LLC | 167,404 | 0.00005% | -23.18% | Other |
CHANGE IN SHARES OUTSTANDING FOR SPRUCE BIOSCIENCES INC
STOCK BUYBACKS FOR SPRUCE BIOSCIENCES INC
Period of Report: 09/30/2023
10-K/10-Q Filings: View
Previous Period
% Change in Shares
Quarter
06/30/2023
0.40%
1Q
03/31/2023
27.62%
2Q
BUYBACK ANNOUNCEMENT(S) FOR SPRUCE BIOSCIENCES INC
LOADING...